Dankner, M.; Dubé, L.-R.; Sorin, M.; Stein, A.J.B.; Nowakowski, A.; Park, C.L.; Magrill, J.; Lazaratos, A.-M.; Romero, J.M.; Batist, G.;
et al. Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-Analysis. Curr. Oncol. 2025, 32, 624.
https://doi.org/10.3390/curroncol32110624
AMA Style
Dankner M, Dubé L-R, Sorin M, Stein AJB, Nowakowski A, Park CL, Magrill J, Lazaratos A-M, Romero JM, Batist G,
et al. Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-Analysis. Current Oncology. 2025; 32(11):624.
https://doi.org/10.3390/curroncol32110624
Chicago/Turabian Style
Dankner, Matthew, Laurie-Rose Dubé, Mark Sorin, Andrew J. B. Stein, Alexander Nowakowski, Changsu Lawrence Park, Jamie Magrill, Anna-Maria Lazaratos, Joan Miguel Romero, Gerald Batist,
and et al. 2025. "Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-Analysis" Current Oncology 32, no. 11: 624.
https://doi.org/10.3390/curroncol32110624
APA Style
Dankner, M., Dubé, L.-R., Sorin, M., Stein, A. J. B., Nowakowski, A., Park, C. L., Magrill, J., Lazaratos, A.-M., Romero, J. M., Batist, G., Kavan, P., Rose, A. A. N., & Ma, K.
(2025). Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-Analysis. Current Oncology, 32(11), 624.
https://doi.org/10.3390/curroncol32110624
